U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07119372) titled 'Study of the Efficacy and Safety of BCD-131 and Mircera(R) in the Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis' on Aug. 07.
Brief Summary: BCD-131 is pegylated darbepoetin beta. This clinical study BCD-131-3 is a randomized, open-label, phase III study of the efficacy and safety of BCD-131 and Mircera used for the treatment of anemia in end-stage chronic kidney disease (CKD) patients on dialysis.
Study Start Date: March 01
Study Type: INTERVENTIONAL
Condition:
Anemia
Chronic Kidney Disease
Chronic Kidney Disease Patients on Hemodialysis
Chronic Kidney Disease 5D
Intervention:
BIOLOGICAL: BCD-131 (peg...